Dr. Luke Kos, M.D

NPI: 1134350028
Total Payments
$156.82
2019 Payments
$29.49
Companies
5
Transactions
11

Payment Breakdown by Category

Food & Beverage$156.82 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $156.82 11 100.0%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $70.53 5 $0 (2019)
UCB, Inc. $39.30 3 $0 (2019)
Valeant Pharmaceuticals North America LLC $18.64 1 $0 (2017)
Shire North American Group Inc $14.21 1 $0 (2018)
Shionogi Inc $14.14 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2019 $29.49 2 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($15.00)
2018 $108.69 8 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($55.53)
2017 $18.64 1 Valeant Pharmaceuticals North America LLC ($18.64)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/17/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.00 General
Category: GASTROENTEROLOGY
04/16/2019 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $14.49 General
Category: Immunology
12/11/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.54 General
Category: GASTROENTEROLOGY
10/22/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC UCERIS (Drug) Food and Beverage In-kind items and services $14.29 General
Category: GASTROENTEROLOGY
07/09/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC MOVIPREP (Drug), XIFAXAN Food and Beverage In-kind items and services $13.26 General
Category: GASTROENTEROLOGY
05/18/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC UCERIS (Drug) Food and Beverage In-kind items and services $14.44 General
Category: GASTROENTEROLOGY
05/02/2018 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $11.83 General
Category: Immunology
02/07/2018 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $12.98 General
Category: Immunology
01/19/2018 Shionogi Inc Symproic (Drug) Food and Beverage In-kind items and services $14.14 General
Category: Gastroenterology
01/17/2018 Shire North American Group Inc GATTEX (Drug) Food and Beverage In-kind items and services $14.21 General
Category: INTERNAL MEDICINE
08/17/2017 Valeant Pharmaceuticals North America LLC UCERIS (Drug), APRISO Food and Beverage In-kind items and services $18.64 General
Category: GASTROENTEROLOGY

About Dr. Luke Kos, M.D

Dr. Luke Kos, M.D is a Anesthesiology healthcare provider based in Morris Plains, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2009. The National Provider Identifier (NPI) number assigned to this provider is 1134350028.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luke Kos, M.D has received a total of $156.82 in payments from pharmaceutical and medical device companies, with $29.49 received in 2019. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($156.82).

Practice Information

  • Specialty Anesthesiology
  • Location Morris Plains, NJ
  • Active Since 07/27/2009
  • Last Updated 03/09/2017
  • Taxonomy Code 207L00000X
  • Entity Type Individual
  • NPI Number 1134350028

Products in Payments

  • UCERIS (Drug) $47.37
  • Cimzia (Drug) $39.30
  • XIFAXAN (Drug) $28.54
  • GATTEX (Drug) $14.21
  • Symproic (Drug) $14.14
  • MOVIPREP (Drug) $13.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anesthesiology Doctors in Morris Plains